Australia- and New York-based, Smileyscope Holding Inc (Smileyscope™) is a global pioneer in virtual and augmented reality (VR/AR) digital therapeutics. The company merges evidence-based medicine with state-of-the-art technology, creating ground-breaking digital treatments that help patients manage pain, anxiety, and mental health.
Smileyscope is honored to have been selected as a member of KidsX 2022 cohort. KidsX is one of the preeminent start-up focused programs in the country, helping to streamline the path to market for the world’s most innovative pediatric products. Dr. Evelyn Chan, CEO and founder of Smileyscope, says “working with KidsX helps us fine tune our business model, messaging, and strategy and allows us to test those improvements with some of the nation's top Children’s Hospitals.”
One of eight companies selected globally, Smileyscope is in an elite cadre of companies that tackle some of the most compelling problems facing healthcare today. Participants are selected by the KidsX member hospitals based on criteria established around their most pressing needs. Just as the companies are helping satisfy the hospital’s needs, the hospitals provide incredible opportunities to the start-ups as well. Smileyscope’s Vice President of Sales & Marketing Gavin West says, “The KidsX program lives up to its reputation. We have already had exposure to the leadership teams of numerous institutions who can make immediate determinations on trials and purchasing.”
About Kids X
KidsX, through the support of The City of Glendale, brings together the top children’s hospitals and talented digital health companies to build, test and deploy software solutions to make pediatric care exceptionally effective, safe, efficient, and convenient for children and families. KidsX supports early-stage digital health companies to achieve product and business model validation in the pediatric market.
Smileyscope™ is a leading pioneer in virtual reality (VR) therapeutics focused on managing pain and anxiety for patients. The company's VR headset and proprietary technology, known as Procedural Choreography, replaces negative real-world stimuli with positive VR stimuli resulting in significant reduction in pain and anxiety. The company currently has multiple clinical trials underway and is rapidly expanding its product offerings into additional patient segments.